SOLIHULL HEALTHCARE PARTNERSHIP
GROVE SURGERY, 3 GROVE ROAD, SOLIHULLCKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
CKD 4 | 2007 | 426 | 499 | 85.4% | |
CKD 4 | 2008 | 398 | 477 | 83.4% | |
CKD 5 | 2009 | 106 | 126 | 84.1% | |
CKD 5 | 2010 | 32 | 38 | 84.2% | |
CKD 5 | 2011 | 49 | 55 | 89.1% | |
CKD 5 | 2012 | 42 | 49 | 85.7% | |
CKD 5 | 2013 | 47 | 52 | 90.4% | |
CKD003 | 2014 | 42 | 43 | 97.7% | |
CKD003 | 2015 | 42 | 43 | 97.7% | |
NM84 | 2016 | 45 | 65 | 69.2% | |
NM84 | 2017 | 65 | 87 | 74.7% | |
NM84 | 2018 | 60 | 90 | 66.7% | |
NM84 | 2019 | 39 | 68 | 57.4% | |
NM84 | 2020 | 76 | 115 | 66.1% | |
NM84 | 2023 | 67 | 98 | 68.4% |